STOCK TITAN

Soleno Therapeutics, Inc. (SLNO) Revenue by Year

SLNO

Soleno Therapeutics, Inc. generated $190.4M in revenue in fiscal year 2025. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Soleno Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $190.4M
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SLNO Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Revenue$190.4MN/AN/AN/AN/AN/AN/AN/AN/A$1.5M+138.8%$607K$0-100.0%$3.0M

SLNO Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$94.6MN/A$66.0M$32.7MN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Soleno Therapeutics, Inc. financials

Frequently Asked Questions

What was Soleno Therapeutics, Inc.'s revenue in fiscal year 2025?

Soleno Therapeutics, Inc. generated $190.4M in revenue in fiscal year 2025.

How has Soleno Therapeutics, Inc.'s revenue changed over the years?

Across the 13 fiscal years this page covers, Soleno Therapeutics, Inc. (SLNO) revenue went from $3.0M in fiscal year 2013 to $190.4M in fiscal year 2025.

What was Soleno Therapeutics, Inc.'s revenue in the most recent quarter?

Soleno Therapeutics, Inc. (SLNO) reported $94.6M in revenue in Q1 2026.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Soleno Therapeutics, Inc. (SLNO) reported on that line in every period on record.